BioRestorative Therapies (BRTX) Other financing activities (2011 - 2025)
BioRestorative Therapies' (BRTX) quarterly Other financing activities came in at -$1246.0 in Q4 2025, down 102.94% on a QoQ basis from $42411.0 in Q1 2025.
BioRestorative Therapies (BRTX) Other financing activities (2011 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has 9 years of Other financing activities data on file, last reported at -$1246.0 in Q4 2025.
- Quarterly Other financing activities changed N/A year-over-year to -$1246.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $41165.0 (changed N/A YoY) and the FY2025 annual result came in at $41165.0, changed N/A from the prior year.
- Other financing activities retreated to -$1246.0 in Q4 2025, from $42411.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1.4 million in Q3 2023 to a low of -$1246.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BioRestorative Therapies | 1.94 Mn | -1.02 Mn | 17,964.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,246.00 |
| Dec 31, 2025 | -1,246.00 |
| Mar 31, 2025 | 42,411.00 |
| Mar 31, 2025 | 42,411.00 |
| Sep 30, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Mar 31, 2018 | 414,168.00 |
| Mar 31, 2018 | 414,168.00 |
| Dec 31, 2017 | 821,250.00 |
| Dec 31, 2017 | 821,250.00 |
| Mar 31, 2017 | 175,000.00 |
| Mar 31, 2017 | 175,000.00 |
| Mar 31, 2016 | 212,898.00 |
| Mar 31, 2016 | 212,898.00 |
| Dec 31, 2015 | 264,144.00 |
| Dec 31, 2015 | 264,144.00 |
| Sep 30, 2015 | -8,050.00 |
| Sep 30, 2015 | -8,050.00 |
| Jun 30, 2015 | 8,050.00 |
| Jun 30, 2015 | 8,050.00 |